Science Applications [SAIC] vs Accenture plc [ACN] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Science Applications International Corp. wins in 8 metrics, Accenture plc wins in 13 metrics, with 0 ties. Accenture plc appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Science Applications International Corp. | Accenture plc | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.49 | 14.61 | Science Applications International Corp. |
| Price-to-Book Ratio | 2.82 | 3.51 | Science Applications International Corp. |
| Debt-to-Equity Ratio | 180.40 | 25.47 | Accenture plc |
| PEG Ratio | -1.94 | 3.79 | Accenture plc |
| EV/EBITDA | 9.75 | 8.63 | Accenture plc |
| Profit Margin (TTM) | 4.93% | 10.61% | Accenture plc |
| Operating Margin (TTM) | 9.09% | 13.82% | Accenture plc |
| EBITDA Margin (TTM) | 9.09% | 13.82% | Accenture plc |
| Return on Equity | 23.27% | 24.76% | Accenture plc |
| Return on Assets (TTM) | 6.34% | 11.16% | Accenture plc |
| Free Cash Flow (TTM) | $577.00M | $10.87B | Accenture plc |
| Dividend Yield | 1.96% | 1.87% | Science Applications International Corp. |
| 1-Year Return | -9.81% | -40.95% | Science Applications International Corp. |
| Price-to-Sales Ratio (TTM) | 0.60 | 1.52 | Science Applications International Corp. |
| Enterprise Value | $6.70B | $109.96B | Accenture plc |
| EV/Revenue Ratio | 0.92 | 1.53 | Science Applications International Corp. |
| Gross Profit Margin (TTM) | 12.63% | 30.26% | Accenture plc |
| Revenue per Share (TTM) | $157 | $116 | Science Applications International Corp. |
| Earnings per Share (Diluted) | $7.70 | $12.20 | Accenture plc |
| Beta (Stock Volatility) | 0.30 | 1.24 | Science Applications International Corp. |
| Short % of Float | 6.81% | 3.32% | Accenture plc |
Science Applications International Corp. vs Accenture plc Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Science Applications International Corp. | 1.21% | 12.86% | 18.45% | 21.51% | 31.08% | 13.35% |
| Accenture plc | -4.72% | 0.61% | -1.49% | -15.47% | -34.97% | -31.74% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Science Applications International Corp. | -9.81% | 2.71% | 11.04% | 86.74% | 249.78% | 249.78% |
| Accenture plc | -40.95% | -39.92% | -33.94% | 57.33% | 235.13% | 570.74% |
Performance & Financial Health Analysis: Science Applications International Corp. vs Accenture plc
| Metric | SAIC | ACN |
|---|---|---|
| Market Information | ||
| Market Cap | $4.30B | $109.72B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 510,571 | 5,264,660 |
| 90 Day Avg. Volume | 646,987 | 6,893,840 |
| Last Close | $114.73 | $177.43 |
| 52 Week Range | $81.08 - $123.41 | $155.82 - $321.77 |
| % from 52W High | -7.03% | -44.86% |
| All-Time High | $156.34 (Nov 04, 2024) | $417.37 (Dec 27, 2021) |
| % from All-Time High | -26.62% | -57.49% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.05% | 0.08% |
| Quarterly Earnings Growth | -0.13% | 0.02% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.11% |
| Operating Margin (TTM) | 0.09% | 0.14% |
| Return on Equity (TTM) | 0.23% | 0.25% |
| Debt to Equity (MRQ) | 180.40 | 25.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $34.09 | $50.76 |
| Cash per Share (MRQ) | $4.19 | $15.32 |
| Operating Cash Flow (TTM) | $609.00M | $13.08B |
| Levered Free Cash Flow (TTM) | $417.25M | $12.16B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.96% | 1.87% |
| Last 12-Month Dividend | $1.85 | $5.73 |
Valuation & Enterprise Metrics Analysis: Science Applications International Corp. vs Accenture plc
| Metric | SAIC (Apr 24, 2026) | ACN (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.49 | 14.61 |
| Forward P/E | 8.90 | 11.96 |
| PEG Ratio | -1.94 | 3.79 |
| Price to Sales (TTM) | 0.60 | 1.52 |
| Price to Book (MRQ) | 2.82 | 3.51 |
| Market Capitalization | ||
| Market Capitalization | $4.30B | $109.72B |
| Enterprise Value | $6.70B | $109.96B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.92 | 1.53 |
| Enterprise to EBITDA | 9.75 | 8.63 |
| Risk & Other Metrics | ||
| Beta | 0.30 | 1.24 |
| Book Value per Share (MRQ) | $34.09 | $50.76 |
Financial Statements Comparison: Science Applications International Corp. vs Accenture plc
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SAIC (2026) | ACN (2025) |
|---|---|---|
| Revenue/Sales | 7.26B | 69.67B |
| Cost of Goods Sold | 6.39B | 47.44B |
| COGS % of Revenue | 88.0% | 68.1% |
| Gross Profit | 872.00M | 22.24B |
| Gross Margin | 12.0% | 31.9% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 521.00M | 10.84B |
| Operating Margin | 7.2% | 15.6% |
| EBITDA | 664.00M | 12.48B |
| EBITDA Margin | 9.1% | 17.9% |
| Pre-Tax Income | 387.00M | 10.27B |
| Pre-Tax Income % of Revenue | 5.3% | 14.7% |
| Income Tax | 29.00M | 2.44B |
| Income Tax % of Revenue | 0.4% | 3.5% |
| Net Income (Profit) | 358.00M | 7.83B |
| Profit Margin | 4.9% | 11.2% |
Balance Sheet & Liquidity Metrics
| Metric | SAIC (2026) | ACN (2025) |
|---|---|---|
| Cash & Equivalents | 182.00M | 11.48B |
| Total Current Assets | 1.18B | 28.90B |
| Total Current Assets % of Revenue | 16.2% | 41.5% |
| Total Current Liabilities | 982.00M | 20.35B |
| Total Current Liabilities % of Revenue | 13.5% | 29.2% |
| Long-Term Debt | 2.67B | 7.34B |
| Long-Term Debt % of Revenue | 36.7% | 10.5% |
| Total Shareholders Equity | 1.50B | 32.24B |
| Retained Earnings | 1.49B | 21.02B |
| Retained Earnings % of Revenue | 20.5% | 30.2% |
| Property, Plant & Equipment | 193.00M | 2.74B |
Cash Flow Statement Comparison
| Metric | SAIC (2026) | ACN (2025) |
|---|---|---|
| Operating Cash Flow | 681.00M | 10.87B |
| Operating Cash Flow % of Revenue | 9.4% | 15.6% |
| Capital Expenditures | N/A | -600.04M |
| Free Cash Flow | 577.00M | 10.87B |
| FCF Margin | 7.9% | 15.6% |
| Debt Repayment | -2.47B | -931.89M |
| Common Stock Repurchase | -445.00M | -4.62B |
Short Interest & Institutional Ownership Analysis
| Metric | SAIC | ACN |
|---|---|---|
| Shares Short | 2.62M | 18.24M |
| Short Ratio | 3.61 | 2.33 |
| Short % of Float | 6.81% | 3.32% |
| Shares Outstanding | 44.00M | 614.84M |
| Float Shares | 42.96M | 612.72M |
| % Held by Insiders | 0.79% | 0.08% |
| % Held by Institutions | 87.56% | 82.92% |
| % Held by Public | 11.65% | 17.00% |
Dividend Analysis & Yield Comparison: Science Applications International Corp. vs Accenture plc
| Metric | SAIC | ACN |
|---|---|---|
| Last 12-Month Dividend | $1.85 | $5.73 |
| Last 12-Month Dividend Yield | 1.96% | 1.87% |
| 3-Year Avg Annual Dividend | $1.60 | $5.39 |
| 3-Year Avg Dividend Yield | 0.32% | 0.41% |
| 3-Year Total Dividends | $4.81 | $16.17 |
| Ex-Dividend Date | Apr 10, 2026 | Apr 10, 2025 |